Poly-L-Lactic Acid Injection for HIV-Associated Facial Lipoatrophy: Treatment Principles, Case Studies, and Literature Review

Aesthetic Surgery Journal

Volumn 28, Issue 4, 2008, Pages 397-403

  Kates, Lisa C ^a   Fitzgerald, Rebecca ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; FILLER; HYALURONIC ACID; HYDROXYAPATITE; POLYLACTIC ACID; RADIESSE;

ADULT; ARTICLE; AUTOTRANSPLANTATION; DILUTION; DISEASE ASSOCIATION; FACE SURGERY; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; HUMAN TISSUE; HYDRATION; INCIDENCE; MALE; PAPULE; PRIORITY JOURNAL; SUBCUTANEOUS TISSUE;

ADULT; COSMETIC TECHNIQUES; FACE; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; INJECTIONS, INTRADERMAL; INJECTIONS, SUBCUTANEOUS; LACTIC ACID; MALE; MIDDLE AGED; POLYMERS; TREATMENT OUTCOME;

EID: 47649103422     PISSN: 1090820X     EISSN: 1527330X     Source Type: Journal    
DOI: 10.1016/j.asj.2008.06.005     Document Type: Article

References (32)

1. James J., Carruthers A., and Carruthers J. HIV-associated facial lipoatrophy. Dermatol Surg 28 (2002) 979-986
2. Carr A., and Cooper D. Adverse effects of antiretroviral therapy. Lancet 356 (2000) 1423-1430
3. Echavez M., and Horstman W. Relationship between lipoatrophy and quality of life. AIDS Read 15 (2005) 369-375
4. Collins E., Wagner C., and Walmsley S. Psychosocial impact of the lipodystrophy syndrome in HIV infection. AIDS Read 10 (2000) 546-550
5. Levan P., Nguyen T., Lallemand F., Mazetier L., Mimoun M., Rozenbaum W., et al. Correction of facial lipoatrophy in HIV-infected patients on highly active antiretroviral therapy for injection of autologous fatty tissue. AIDS 16 (2002) 1985-1987
6. Fernandez E., and Mackey C. Soft tissue augmentation: a review. J Drugs Dermatol 5 (2006) 630-641
7. Werschler W., and Weinkle S. Longevity of effects of injectable products for soft tissue augmentation. J Drugs Dermatol 4 (2005) 20-27
8. Comite S., Liu J., Balasubramanian S., and Christian M. Treatment of HIV-associated facial lipoatrophy with Radiance FN (Radiesse). Dermatol Online J 10 (2004) 2
9. Silvers S., Eviatar J., Echavez M., and Pappas A. Prospective open-label, 18-month trial of calcium hydroxylapatite (Radiesse) for facial soft-tissue augmentation in patients with human immunodeficiency virus-associated lipoatrophy: one-year durability. Plast Reconstr Surg 118 Suppl 3 (2006) 34S-45S
10. Jacovella P., Peiretti C., Cunille D., Salzamendi M., and Schechtel S. Long-lasting results with hydroxylapatite (Radiesse) facial filler. Plast Reconstr Surg 118 Suppl 3 (2006) 15S-21S
11. Jones D., Carruthers A., and Orentreich D. Highly purified 1000-cSt silicone oil for treatment of human immunodeficiency virus-associated facial lipoatrophy: an open pilot trial. Dermatol Surg 30 (2004) 1279-1286
12. Cohen S., and Holmes R. Artecoll: a long-lasting injectable wrinkle filler material: a report of a controlled, randomized, multicenter clinical trial of 251 subjects. Plast Reconstr Surg 114 (2004) 964-976
13. Kronenthal R. Biodegradable polymers in medicine. In: Knonenthal R., Oser, and Martin E. (Eds). Polymers science and technology vol 8 (1975), Pleum Press, New York 119-137
14. Rotunda A., and Narins R. Poly-L-lactic acid: a new dimension in soft tissue augmentation. Dermatol Ther 19 (2006) 151-158
15. Simamora P., and Chern W. Poly-L-lactic acid: an overview. J Drugs Dermatol 5 (2006) 436-440
16. Vleggaar D. Facial volumetric correction with injectable poly-L-lactic acid. Dermatol Surg 31 (2005) 1511-1518
17. Engelhard P., Humble G., and Mest D. Safety of Sculptra: a review of clinical trial data. J Cosmet Laser Ther 7 (2005) 201-205
18. Sadick, and Burgess C. Clinical experience of adverse outcomes associated with poly-L-lactic acid. J Drugs Dermatol 6 Suppl 1 (2007) 4S-8S
19. Vleggaar D., and Bauer U. Facial enhancement and the European experience with Sculptra (poly-L-lactic acid). J Drugs Dermatol 3 (2004) 542-547
20. Sculptra [package insert] (June 2006), Dermik Laboratories, Bridgewater, NJ
21. Moyle G., Lysakova L., Brown S., Sibtain N., Healy J., Priest C., et al. A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Med 5 (2004) 82-87
22. Valantin M., Aubron-Olivier C., Ghosn J., Laglenne E., Pauchard M., Schoen H., et al. Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA. AIDS 17 (2003) 2471-2477
23. Mest D., and Humble G. Safety and efficacy of intradermal implants of poly-L-lactic acid (Sculptra) in persons with HIV-associated lipoatrophy. Antiviral Ther 9 (2004) 36
24. Engelhard P, Knives M. Safety and efficacy of New-Fill (Polylactic acid) in the treatment of HIV-associated lipoatrophy of the face (HALF) [abstract]. Internationl Conference on AIDS, July 7-12, 2002. Abstract no. WePeB6011.
25. Burgess C., and Quiroga R. Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy. J Am Acad Dermatol 52 (2005) 233-239
26. Lafaurie M., Dolivo M., Porcher R., Rudant J., Madelaine I., and Molina J. Treatment of facial lipoatrophy with intradermal injections of polylactic acid in HIV-infected patients. J Acquir Immune Defic Syndr 38 (2005) 393-398
27. Borelli C., Kunte C., Weisenseel P., Thoma-Greber E., Korting H., and Konz B. Deep subcutaneous application of poly-L-lactic acid as a filler for facial lipoatrophy in HIV-infected patients. Skin Pharmacol Physiol 18 (2005) 273-278
28. Cattelan A., Bauer U., Trevenzoli M., Sasset L., Campostrini S., Facchin C., et al. Use of polylactic acid implants to correct facial lipoatrophy in human immunodeficiency virus 1-positive individuals receiving combination antiretroviral therapy. Arch Dermatol 142 (2006) 329-334
29. Bodokh I., and Simonet P. Polylactic acid injections (Newfill) in the treatment of facial lipodystrophy in HIV-positive patients. Ann Dermatol Venereol 133 (2006) 429-432
30. Piquet M., Brignol L., Chatelain B., Rey D., Ricbourg B., and Meyer C. Polylactic acid injections: usefullness for the treatment of facial lipoatrophy in HIV + patients under tritherapy [in French]. Rev Stomatol Chir Maxillofac 108 (2007) 496-504
31. Hanke C., and Redbord K. Safety and efficacy of poly-L-lactic acid in HIV lipoatrophy and lipoatrophy of aging. J Drugs Dermatol 6 (2007) 123-128
32. Mest D., and Humble G. Safety and efficacy of poly-L-lactic acid injections in persons with HIV-associated lipoatrophy: the US experience. Dermatol Surg 32 (2006) 1336-1345